Swedish food supplement firm Wellma Group AB is planning a sale, with owner Systematic Growth working with an adviser on a potential divestment that could value the company at more than €1 billion ($1.1 billion), people with knowledge of the matter said. The sales process is expected to launch in October, though deliberations are at an early stage and the firm could decide to keep the asset longer. A representative for Systematic Growth declined to comment.

Wellma, based in Stockholm, is a contract developer and manufacturer of food supplements, nutraceuticals, and pharmaceuticals for wellness brands. It operates 15 production sites, serves over 50 markets globally, and offers more than 5,000 formulations, according to its website.